Guaifenesin Tablet, Extended Release
Product Images NDC 0363-0028

1 FDA label image from Walgreen Co. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 0363-0028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Walgreen Co., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (600 mg (20 Tablet Label))

Package Label-principal Display Panel (600 mg (20 Tablet Label))
The packaging label for Walgreens Guaifenesin Extended-Release Tablets, 600 mg. The front highlights 12-hour mucus relief with expectorant action, including relief of chest congestion and thinning mucus. The box contains 20 extended-release tablets. The back panel shows the Drug Facts, warnings, directions, inactive ingredients, contact information, and distributor details by Walgreens Co. The label features a barcode and states the tablets are made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.